- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 30/50 - Conditioning of the sorbent material or stationary liquid
Patent holdings for IPC class G01N 30/50
Total number of patents in this class: 105
10-year publication summary
6
|
5
|
9
|
6
|
7
|
4
|
11
|
6
|
3
|
11
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Shimadzu Corporation | 6187 |
6 |
Waters Technologies Corporation | 1700 |
6 |
GE Healthcare Bio-Sciences AB | 540 |
5 |
Regeneron Pharmaceuticals, Inc. | 4303 |
5 |
Cytiva Sweden AB | 764 |
4 |
Bristol-myers Squibb Company | 4872 |
3 |
JSR Corporation | 2526 |
3 |
Bio-Rad Laboratories, Inc. | 1617 |
3 |
Quest Diagnostics Investments LLC | 409 |
3 |
Repligen Corporation | 285 |
3 |
Biotage AB | 91 |
2 |
Genzyme Corporation | 1269 |
2 |
Global Life Sciences Solutions USA LLC | 502 |
2 |
Cytiva BioProcess R&D AB | 306 |
2 |
F. Hoffmann-La Roche AG | 7939 |
1 |
Hoffmann-La Roche Inc. | 3454 |
1 |
ExxonMobil Research And Engineering Company | 2566 |
1 |
Merck Patent GmbH | 5814 |
1 |
Amgen Inc. | 4093 |
1 |
Hitachi, Ltd. | 15531 |
1 |
Other owners | 50 |